CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- DEF 14A Proxy Proxy Statement
- 10KSB Other 10KSB
- NTN 10K Other NTN 10K
- SC 13D/A Stake Beneficial Ownership Report
- 10QSB Other 10QSB
- 8-K/A Event Item 4 · Item 7
- 8-K Event Item 4 · Item 7
- 10QSB Other 10QSB
- SC 13D Stake Beneficial Ownership Report
- POS AM Other Post-effective Amendment for Registration Statement
- 10QSB Other 10QSB
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- 10KSB Other 10KSB
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 10QSB Other 10QSB
- 10QSB Other 10QSB
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
Page 35 of 36 · 707 filings